SCHEMBL4854283

SCHEMBL4854283

C=CC(C)(C)c1ccc(OCCN(C)C)c(C(=O)C=Cc2ccc(O)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.45
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
MAOB P27338 4/20 0.42
MAOA P21397 2/20 0.42
CAPN1 P07384 1/20 0.42
PARP1 P09874 1/20 0.42
ACHE P22303 2/20 0.41
XDH P47989 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
MCL1 Q07820 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849818 0.90 KDM4E (0.51) BCHENFKB1NFKB2RELAMAOB
SCHEMBL4849756 0.90 KDM4E (0.51) BCHENFKB1NFKB2RELAMAOB
SCHEMBL4854287 0.83 PTPN1 (0.55) BCHECAPN1ACHELMNAPOLB
SCHEMBL4853687 0.82 PTPN1 (0.38) BCHEMAOBMAOAACHE
SCHEMBL4852534 0.82 PTPN1 (0.38) BCHEMAOBMAOAACHE
SCHEMBL4848110 0.79 BCHE (0.51) BCHEMAOBMAOACAPN1PARP1
SCHEMBL4853434 0.79 BCHE (0.51) BCHEMAOBMAOACAPN1PARP1
SCHEMBL4852212 0.78 BCHE (0.44) BCHEMAOBMAOACAPN1PARP1
SCHEMBL4853723 0.78 BCHE (0.44) BCHEMAOBMAOACAPN1PARP1
SCHEMBL4856299 0.78 MCL1 (0.50) BCHEMAOBACHEMCL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed